1-3 of 3
Eli Estey
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcome of Allogeneic Stem Cell Transplantation after Hypomethylating Therapy with 2′-Deoxy-5 Azacytidine for Patients with Myelodysplastic Syndrome.

Leandro De Padua Silva, MD, Marcos de Lima, MD, Hagop Kantarjian, MD, Richard Champlin, MD, Stefan Faderl, MD, Sergio Giralt, MD, Partow Kebriaei, MD, Jan Davisson, RN, Eli Estey, MD, Guillermo Garcia-Manero, MD, Jean-Pierre Issa, MD, Farhad Ravandi, MD
Journal: Blood
Blood (2007) 110 (11): 1468.
https://doi.org/10.1182/blood.V110.11.1468.1468
Published: 2007
Journal Articles

Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412

Clinical Trials & Observations
Richard M. Stone, Daniel J. DeAngelo, Virginia Klimek, Ilene Galinsky, Eli Estey, Stephen D. Nimer, Wilson Grandin, David Lebwohl, Yanfeng Wang, Pamela Cohen, Edward A. Fox, Donna Neuberg, Jennifer Clark, D. Gary Gilliland, James D. Griffin
Journal: Blood
Blood (2005) 105 (1): 54–60.
https://doi.org/10.1182/blood-2004-03-0891
Published: 2005
Journal Articles

Identification of a novel activating mutation (Y842C) within the activation loop of FLT3 in patients with acute myeloid leukemia (AML)

Thomas Kindler, Frank Breitenbuecher, Stefan Kasper, Eli Estey, Francis Giles, Eric Feldman, Gerhard Ehninger, Gary Schiller, Virginia Klimek, Stephen D. Nimer, Alois Gratwohl, Chuna Ram Choudhary, Constan Mueller-Tidow, Hubert Serve, Harald Gschaidmeier, Pamela S. Cohen, Christoph Huber, Thomas Fischer
Journal: Blood
Blood (2005) 105 (1): 335–340.
https://doi.org/10.1182/blood-2004-02-0660
Published: 2005